Sign in

NCT06725069Completed

Effects of Neuromuscular Electrical Stimulation on Flexor Spasticity and Function in Stroke Patients

Effects of Neuromuscular Electrical Stimulation Applied to Agonist or Antagonist Muscles of the Upper Extremity on Flexor Spasticity and Function in Patients With Stroke

Source: ClinicalTrials.gov · Last updated 2 Apr 2025

Brief summary (registry, in English)

In this study, the investigators aimed to determine the effects of botulinum neurotoxin type A injections for wrist and finger flexor spasticity and neuromuscular electrical stimulation therapy applied to wrist and finger flexors or extensors on upper extremity flexor spasticity and function in stroke patients.

Status (registry)
Completed
Study type
Observational
Enrollment
36 (actual)
First submitted
1 Dec 2024
Start date
1 Feb 2024
Primary completion date
31 Oct 2024
Lead sponsor
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Diseases
Stroke
NCT number
NCT06725069

What you commit to

  • Study type: Observational
  • Participants enrolled: 36
  • From 1 Feb 2024 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having received neurolytic therapy, BoNT-A injection or NMES treatment in the last 3 months
  • Complex regional pain syndrome (CRPS), sequelae of previous trauma or surgery (muscle tendon adhesion, peripheral nerve damage) in the affected extremity

Other illness

  • Presence of another neurological disorder other than stroke causing motor impairment/spasticity
  • Skin problem (disease, allergy, infection, etc.) on the contact surface of the NMES
  • Epilepsy
  • Malignancy

Other

  • Fixed contracture in the hand-wrist
  • Use of medical treatment for spasticity
  • Having a pacemaker

Who the study is looking for

  • Diagnosed with ischemic or hemorhagic stroke after imaging with CT/MRI
  • First time stroke survivor
  • between 45-75 years old
  • Stroke duration \> 3 months
  • Neurologically stable
  • Affected wrist and finger flexor muscle spasticity with MAS≥2
  • Patients whose cognitive status is at a level to understand the study instructions MMT\> 23)

Age in the registry: 45 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
SBÜ Gaziler Fizik Tedavi ve Rehabilitasyon Eğitim ve Araştırma Hastanesi
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.